Correlation Between SenesTech and Novozymes A/S

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both SenesTech and Novozymes A/S at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining SenesTech and Novozymes A/S into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between SenesTech and Novozymes AS B, you can compare the effects of market volatilities on SenesTech and Novozymes A/S and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in SenesTech with a short position of Novozymes A/S. Check out your portfolio center. Please also check ongoing floating volatility patterns of SenesTech and Novozymes A/S.

Diversification Opportunities for SenesTech and Novozymes A/S

0.11
  Correlation Coefficient

Average diversification

The 3 months correlation between SenesTech and Novozymes is 0.11. Overlapping area represents the amount of risk that can be diversified away by holding SenesTech and Novozymes AS B in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Novozymes AS B and SenesTech is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on SenesTech are associated (or correlated) with Novozymes A/S. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Novozymes AS B has no effect on the direction of SenesTech i.e., SenesTech and Novozymes A/S go up and down completely randomly.

Pair Corralation between SenesTech and Novozymes A/S

Given the investment horizon of 90 days SenesTech is expected to under-perform the Novozymes A/S. In addition to that, SenesTech is 2.54 times more volatile than Novozymes AS B. It trades about -0.12 of its total potential returns per unit of risk. Novozymes AS B is currently generating about -0.14 per unit of volatility. If you would invest  6,300  in Novozymes AS B on August 28, 2024 and sell it today you would lose (445.00) from holding Novozymes AS B or give up 7.06% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

SenesTech  vs.  Novozymes AS B

 Performance 
       Timeline  
SenesTech 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days SenesTech has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's technical and fundamental indicators remain comparatively stable which may send shares a bit higher in December 2024. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.
Novozymes AS B 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Novozymes AS B has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest fragile performance, the Stock's primary indicators remain stable and the current disturbance on Wall Street may also be a sign of long-run gains for the company stockholders.

SenesTech and Novozymes A/S Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with SenesTech and Novozymes A/S

The main advantage of trading using opposite SenesTech and Novozymes A/S positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if SenesTech position performs unexpectedly, Novozymes A/S can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Novozymes A/S will offset losses from the drop in Novozymes A/S's long position.
The idea behind SenesTech and Novozymes AS B pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.

Other Complementary Tools

Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device